ZNF92 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.570000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.914000E-01
Normal-vs-Stage2
5.628400E-02
Normal-vs-Stage3
2.243600E-01
Normal-vs-Stage4
3.559600E-01
Stage1-vs-Stage2
4.980800E-01
Stage1-vs-Stage3
7.045600E-02
Stage1-vs-Stage4
7.876400E-01
Stage2-vs-Stage3
2.809400E-01
Stage2-vs-Stage4
7.957400E-01
Stage3-vs-Stage4
2.577400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.706200E-02
Normal-vs-AfricanAmerican
2.467600E-01
Normal-vs-Asian
4.236000E-02
Caucasian-vs-AfricanAmerican
7.546400E-01
Caucasian-vs-Asian
3.406600E-01
AfricanAmerican-vs-Asian
2.652400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.382000E-02
Normal-vs-Female
7.419700E-02
Male-vs-Female
8.740400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.168400E-01
Normal-vs-Age(41-60Yrs)
1.910760E-01
Normal-vs-Age(61-80Yrs)
4.657800E-02
Normal-vs-Age(81-100Yrs)
4.700400E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.225600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.134800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.068600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.039700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.824000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.758600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.625000E-01
Normal-vs-Daily Drinker
4.386000E-02
Normal-vs-Weekly Drinker
8.620100E-02
Normal-vs-Occasional Drinker
1.243030E-01
Normal-vs-Social Drinker
3.925000E-01
Non Drinker-vs-Daily Drinker
5.845400E-01
Non Drinker-vs-Weekly Drinker
7.488200E-01
Non Drinker-vs-Occasional Drinker
5.925500E-02
Non Drinker-vs-Social Drinker
8.121800E-02
Daily Drinker-vs-Weekly Drinker
9.110800E-01
Daily Drinker-vs-Occasional Drinker
2.569200E-01
Daily Drinker-vs-Social Drinker
1.427990E-01
Weekly Drinker-vs-Occasional Drinker
2.937000E-01
Weekly Drinker-vs-Social Drinker
1.999180E-01
Occasional Drinker-vs-Social Drinker
5.671600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.197800E-01
Normal-vs-Grade 2
9.102000E-01
Normal-vs-Grade 3
8.846600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.030600E-01
Grade 1-vs-Grade 3
4.775400E-01
Grade 1-vs-Grade 4
6.197800E-01
Grade 2-vs-Grade 3
6.415200E-01
Grade 2-vs-Grade 4
9.102000E-01
Grade 3-vs-Grade 4
8.846600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.000200E-02
Normal-vs-NonDiabetic
6.704400E-02
Diabetic-vs-NonDiabetic
1.777650E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.132000E-02
Normal-vs-NoPancreatitis
5.476300E-02
Pancreatitis-vs-NoPancreatitis
2.615800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.255560E-01
Normal-vs-N1
5.083600E-02
N0-vs-N1
8.321800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.055600E-01
Normal-vs-TP53-NonMutant
3.680800E-01
TP53-Mutant-vs-TP53-NonMutant
4.504600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
